Panel & Audience Discussion: Let’s Collaborate: Exploring What Big Pharma’s External Innovation & Partnership Directors Are Looking for in Antigen-Specific Tolerance Approaches
Time: 2:15 pm
day: Conference Day One
- Starting at the beginning and working towards the clinic – what are the key points and factors that we look out for?
- This is your opportunity to ask your burning questions and hear from the external innovators in this interactive and candid session set to accelerate your 2024 business goals